임상시험용 영상 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품 및 서비스별, 모달리티별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)
Clinical Trial Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Service, By Modality, By End-User, By Region, By Competition, 2020-2030F
상품코드:1886288
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 임상시험용 영상 진단 시장은 2024년에 11억 8,000만 달러로 평가되며, 2030년까지 CAGR 7.30%로 성장하며, 18억 달러에 달할 것으로 예측됩니다. 임상시험용 영상 진단 시장은 자기공명영상(MRI), 컴퓨터단층촬영(CT), 양전자방출단층촬영(PET) 등 의료용 영상 진단 기법을 적용하여 임상개발 단계에 걸쳐 임상시험용 의약품의 안전성과 유효성을 객관적으로 평가할 수 있는 분야를 포괄합니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
11억 8,000만 달러
시장 규모 : 2030년
18억 달러
CAGR : 2025-2030년
7.30%
가장 빠르게 성장하는 부문
컴퓨터 단층촬영(CT)
최대 시장
북미
주요 시장 성장 촉진요인
제약회사와 생명공학 기업이 치료 파이프라인을 확장하는 가운데, 전 세계 임상시험 건수 증가는 임상시험용 영상 진단 시장의 근본적인 촉진요인으로 작용하고 있습니다. 이에 따라 의약품의 안전성 및 유효성 평가를 위한 종합적인 영상 진단이 필요하게 되었고, 전문 서비스에 대한 수요가 직접적으로 증가하고 있습니다.
주요 시장 과제
영상 진단 장비에 필요한 막대한 설비투자는 세계 임상시험 영상 진단 시장의 성장을 직접적으로 저해하고 있습니다. 자기공명영상 진단장치(MRI), 양전자방출단층촬영장치(PET) 등 첨단 의료영상 진단장치의 도입 및 유지에 소요되는 고가의 비용은 임상시험 실시기관 및 임상시험수탁기관(CRO)에 큰 재정적 부담으로 작용하고 있습니다.
주요 시장 동향
분산형 및 하이브리드 임상시험 모델의 채택은 환자 접근성 향상과 데이터 수집의 효율화를 통해 전 세계 임상시험 이미징 시장의 운영 전략을 근본적으로 재구성하고 있습니다. 이 접근 방식은 원격의료 및 웨어러블 기기 등 원격 기술을 통합하여 환자의 대규모 현지 방문의 필요성을 줄이고, 참가자 모집의 지역적 범위를 확대합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 임상시험용 영상 진단 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품·서비스별(임상시험 디자인 컨설팅 서비스, 독영 분석 서비스, 운영 이미징 서비스, 이미징 소프트웨어)
모달리티별(자기공명영상, 컴퓨터 단층촬영, 초음파, 양전자 방출 단층촬영, X선, 심장 초음파 검사, 기타 모달리티)
최종사용자별(제약·바이오테크놀러지 기업, 의료기기 제조업체, 학술·정부 조사기관)
지역별
기업별(2024)
시장 맵
제6장 북미의 임상시험용 영상 진단 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 임상시험용 영상 진단 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 임상시험용 영상 진단 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 임상시험용 영상 진단 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 임상시험용 영상 진단 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 임상시험용 영상 진단 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Clario Medical Imaging Inc
Icon PLC
Ixico PLC
Koninklijke Philips N.V
Medpace
Navitas Clinical Research, Inc
Parexel International Corporation
ProScan Imaging
Radiant Sage LLC
Resonance Health
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Clinical Trial Imaging Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 7.30% to reach USD 1.80 Billion by 2030. The clinical trial imaging market encompasses the application of medical imaging modalities, such as Magnetic Resonance Imaging, Computed Tomography, and Positron Emission Tomography, to objectively assess the safety and efficacy of investigational therapeutics throughout clinical development.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.18 Billion
Market Size 2030
USD 1.80 Billion
CAGR 2025-2030
7.30%
Fastest Growing Segment
Computed Tomography
Largest Market
North America
Key Market Drivers
The increasing global clinical trial volume is a fundamental driver for the clinical trial imaging market as pharmaceutical and biotechnology companies expand therapeutic pipelines. This expansion necessitates comprehensive imaging for drug safety and efficacy assessments, directly increasing demand for specialized services. This growth is evidenced by the rising number of registered studies; according to ClinicalTrials. gov, as of October 10, 2025, the number of registered studies reached 74,339.
Key Market Challenges
The substantial capital expenditure required for imaging equipment directly impedes the growth of the Global Clinical Trial Imaging Market. The high cost of acquiring and maintaining advanced medical imaging modalities, such as Magnetic Resonance Imaging or Positron Emission Tomography systems, places a significant financial burden on clinical trial sites and contract research organizations. This barrier limits the ability of many entities, particularly smaller or emerging research centers, to invest in the latest technology or expand their imaging capabilities.
Key Market Trends
The adoption of decentralized and hybrid clinical trial models is fundamentally reshaping operational strategies within the global clinical trial imaging market by enhancing patient accessibility and streamlining data collection. This approach integrates remote technologies such as telemedicine and wearable devices, reducing the need for extensive on-site patient visits and thereby broadening the geographic reach for participant recruitment. TransCelerate BioPharma's 2024 Annual Report indicates that both mature and newer initiatives have achieved 75% or higher adoption rates among their member companies in recent years, reflecting the increasing integration of flexible trial designs.
Key Market Players
Clario Medical Imaging Inc
Icon PLC
Ixico PLC
Koninklijke Philips N.V
Medpace
Navitas Clinical Research, Inc
Parexel International Corporation
ProScan Imaging
Radiant Sage LLC
Resonance Health
Report Scope:
In this report, the Global Clinical Trial Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Clinical Trial Imaging Market, By Product and Service:
Trial Design Consulting Services
Read Analysis Services
Operational Imaging Services
Imaging Software
Clinical Trial Imaging Market, By Modality:
Magnetic Resonance Imaging
Computed Tomography
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities
Clinical Trial Imaging Market, By End User:
Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers
Academic and Government Research Institute
Clinical Trial Imaging Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Trial Imaging Market.
Available Customizations:
Global Clinical Trial Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Clinical Trial Imaging Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software)
5.2.2. By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities)
5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic and Government Research Institute)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Clinical Trial Imaging Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product and Service
6.2.2. By Modality
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Clinical Trial Imaging Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product and Service
6.3.1.2.2. By Modality
6.3.1.2.3. By End User
6.3.2. Canada Clinical Trial Imaging Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product and Service
6.3.2.2.2. By Modality
6.3.2.2.3. By End User
6.3.3. Mexico Clinical Trial Imaging Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product and Service
6.3.3.2.2. By Modality
6.3.3.2.3. By End User
7. Europe Clinical Trial Imaging Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product and Service
7.2.2. By Modality
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Clinical Trial Imaging Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product and Service
7.3.1.2.2. By Modality
7.3.1.2.3. By End User
7.3.2. France Clinical Trial Imaging Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product and Service
7.3.2.2.2. By Modality
7.3.2.2.3. By End User
7.3.3. United Kingdom Clinical Trial Imaging Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product and Service
7.3.3.2.2. By Modality
7.3.3.2.3. By End User
7.3.4. Italy Clinical Trial Imaging Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product and Service
7.3.4.2.2. By Modality
7.3.4.2.3. By End User
7.3.5. Spain Clinical Trial Imaging Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product and Service
7.3.5.2.2. By Modality
7.3.5.2.3. By End User
8. Asia Pacific Clinical Trial Imaging Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product and Service
8.2.2. By Modality
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Clinical Trial Imaging Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product and Service
8.3.1.2.2. By Modality
8.3.1.2.3. By End User
8.3.2. India Clinical Trial Imaging Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product and Service
8.3.2.2.2. By Modality
8.3.2.2.3. By End User
8.3.3. Japan Clinical Trial Imaging Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product and Service
8.3.3.2.2. By Modality
8.3.3.2.3. By End User
8.3.4. South Korea Clinical Trial Imaging Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product and Service
8.3.4.2.2. By Modality
8.3.4.2.3. By End User
8.3.5. Australia Clinical Trial Imaging Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product and Service
8.3.5.2.2. By Modality
8.3.5.2.3. By End User
9. Middle East & Africa Clinical Trial Imaging Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product and Service
9.2.2. By Modality
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Clinical Trial Imaging Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product and Service
9.3.1.2.2. By Modality
9.3.1.2.3. By End User
9.3.2. UAE Clinical Trial Imaging Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product and Service
9.3.2.2.2. By Modality
9.3.2.2.3. By End User
9.3.3. South Africa Clinical Trial Imaging Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product and Service
9.3.3.2.2. By Modality
9.3.3.2.3. By End User
10. South America Clinical Trial Imaging Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product and Service
10.2.2. By Modality
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Clinical Trial Imaging Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product and Service
10.3.1.2.2. By Modality
10.3.1.2.3. By End User
10.3.2. Colombia Clinical Trial Imaging Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product and Service
10.3.2.2.2. By Modality
10.3.2.2.3. By End User
10.3.3. Argentina Clinical Trial Imaging Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product and Service
10.3.3.2.2. By Modality
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Clinical Trial Imaging Market: SWOT Analysis
